RN7SL688P

Across TCGA pan-cancer cohorts, RN7SL688P RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RN7SL688P’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where RN7SL688P RNA is repressed in tumor relative to normal tissue. In most cancer types RN7SL688P is over-expressed in tumor, although a few such as THCA and UCEC show the opposite, repressed pattern.

THCA, UCEC, and LIHC are the cancer types where RN7SL688P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL688P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Female	All	−0.313	<.001	5	view →
UCEC	All	All	−0.171	.011	2	view →
LIHC	All	All	+0.049	.007	2	view →
LUAD	All	All	+0.233	.011	1	view →
LUSC	All	II,III,IV	+0.143	.036	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

RN7SL688P–THCA

Open the THCA breakdown →